BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12419647)

  • 1. Emesis: antiemetic effect of cyclophosphamide at central receptors of multitransmitter system in the cat.
    Bosnjak S; Beleslin DB
    Pharmacol Res; 2002 Nov; 46(5):425-34. PubMed ID: 12419647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonidine-induced emesis: a multitransmitter pathway concept.
    Japundzić-Zigon N; Samardzić R; Beleslin DB
    Pharmacol Res; 1997 Apr; 35(4):287-97. PubMed ID: 9264044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential inhibition by ethanol of norepinephrine- and clonidine-induced emesis in cats.
    Beleslin DB; Jovanović-Mićić D; Japundzić N; Nikolić SB; Samardzić R
    Alcohol; 1992; 9(5):389-93. PubMed ID: 1418663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noradrenaline-induced emesis. Alpha-2 adrenoceptor mediation in the area postrema.
    Beleslin DB; Strbac M
    Neuropharmacology; 1987 Aug; 26(8):1157-65. PubMed ID: 2889165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Area postrema: cholinergic and noradrenergic regulation of emesis. A new concept.
    Beleslin DB; Strbac M; Jovanović-Mićić D; Samardzić R; Nedelkovski V
    Arch Int Physiol Biochim; 1989 Feb; 97(1):107-15. PubMed ID: 2475081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emesis induced by 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343): evidence for a predominant central muscarinic M1 mediation.
    Beleslin DB; Nedelkovski V
    Neuropharmacology; 1988 Sep; 27(9):949-56. PubMed ID: 2460797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of the area postrema and emesis.
    Jovanović-Mićić D; Strbac M; Krstić SK; Japundzić N; Samardzić R; Beleslin DB
    Metab Brain Dis; 1989 Mar; 4(1):55-60. PubMed ID: 2704346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emesis induced in domestic pigs: a new experimental tool for detection of antiemetic drugs and for evaluation of emetogenic potential of new anticancer agents.
    Szelenyi I; Herold H; Göthert M
    J Pharmacol Toxicol Methods; 1994 Oct; 32(2):109-16. PubMed ID: 7865862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of alpha-adrenergic mechanisms within the area postrema in dopamine-induced emesis.
    Jovanović-Mićić D; Samardzić R; Beleslin DB
    Eur J Pharmacol; 1995 Jan; 272(1):21-30. PubMed ID: 7713146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vomiting induced by cyclophosphamide and phosphoramide mustard in cats.
    Fetting JH; McCarthy LE; Borison HL; Colvin M
    Cancer Treat Rep; 1982 Aug; 66(8):1625-9. PubMed ID: 7105052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiemetic profile of Y-25130, a new selective 5-HT3 receptor antagonist.
    Fukuda T; Setoguchi M; Inaba K; Shoji H; Tahara T
    Eur J Pharmacol; 1991 Apr; 196(3):299-305. PubMed ID: 1654255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rostral hypothalamus: a new neuroanatomical site of neurochemically-induced emesis in the cat.
    Beleslin DB; Rezvani AH; Myers RD
    Brain Res Bull; 1987 Aug; 19(2):239-44. PubMed ID: 2889512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-emetic mechanisms of Zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlates.
    Ullah I; Subhan F; Ayaz M; Shah R; Ali G; Haq IU; Ullah S
    BMC Complement Altern Med; 2015 Feb; 15():34. PubMed ID: 25888212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified oral ondansetron regimen for cyclophosphamide-induced emesis in lupus nephritis.
    Yarboro CH; Wesley R; Amantea MA; Klippel JH; Pucino F
    Ann Pharmacother; 1996; 30(7-8):752-5. PubMed ID: 8826554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on nicotine-induced emesis: nicotinic mediation in area postrema.
    Beleslin DB; Krstić SK
    Physiol Behav; 1987; 39(6):681-6. PubMed ID: 3602120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-induced emesis: management of early and delayed emesis in milder emetogenic regimens.
    Barrenetxea G; Schneider J; Centeno MM; Romero H; de la Rica M; Rodríguez-Escudero FJ
    Cancer Chemother Pharmacol; 1996; 38(5):471-5. PubMed ID: 8765442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
    Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central antiemetic effects of AS-8112, a dopamine D2, D3, and 5-HT(3) receptor antagonist, in ferrets.
    Yoshikawa T; Yoshida N; Oka M
    Eur J Pharmacol; 2001 Nov; 431(3):361-4. PubMed ID: 11730730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparative Study of the Antiemetic Effects of α
    Sun Y; Darmani NA
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiemetic effect of a potent and selective neurokinin-1 receptor antagonist, FK886, on cisplatin-induced acute and delayed emesis in ferrets.
    Furukawa TY; Nakayama H; Imazumi K; Yamakuni H; Takeshita K; Matsuo M; Manda T; Uchida W
    Biol Pharm Bull; 2014; 37(2):232-8. PubMed ID: 24492720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.